Listen "Quickfire Updates on Gastric/GEJ Cancers: Latest Data in Perioperative Immunotherapy"
Episode Synopsis
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
More episodes of the podcast Keeping Current
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies
24/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies
12/12/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.